Serum DHCR24 Auto-antibody as a new Biomarker for Progression of Hepatitis C
Background: New biomarkers are needed to identify the stage of hepatitis C virus (HCV)-infected diseases in order to reduce the mortality rates. Herein, we investigated whether serum 3β-hydroxysterol Δ24-reductase antibody (DHCR24 Ab) may serve as a prognostic marker for hepatitis C infection progre...
Main Authors: | Sayeh Ezzikouri, Kiminori Kimura, Hajime Sunagozaka, Shuichi Kaneko, Kazuaki Inoue, Tomohiro Nishimura, Tsunekazu Hishima, Michinori Kohara, Kyoko Tsukiyama-Kohara |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-06-01
|
Series: | EBioMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396415001012 |
Similar Items
-
Signaling regulates activity of DHCR24, the final enzyme in cholesterol synthesis[S]
by: Winnie Luu, et al.
Published: (2014-03-01) -
Role of Oxidative Stress in Hepatocarcinogenesis Induced by Hepatitis C Virus
by: Kyoko Tsukiyama-Kohara
Published: (2012-11-01) -
The Involvement of 3β-hydroxysterol-Δ^24-reductase, A Post-squalene Enzyme in Cholesterol Biosynthesis, in Desmosterolosis
by: Zadworny, David, et al.
Published: (2003) -
Elevated autophagy and mitochondrial dysfunction in the Smith–Lemli–Opitz Syndrome
by: Shaohua Chang, et al.
Published: (2014-01-01) -
The terminal enzymes of cholesterol synthesis, DHCR24 and DHCR7, interact physically and functionally[S]
by: Winnie Luu, et al.
Published: (2015-04-01)